- SEC postpones crypto ETF decision impacting market sentiment.
- Review extended to October 2025.
- Potential implications for BTC, ETH, and other assets.
The SEC has delayed its decision on the Truth Social Bitcoin and Ethereum ETF, affecting several crypto ETFs including BTC, ETH, SOL, and XRP, until October 8, 2025.
This delay influences market expectations and ETF liquidity, raising questions about regulatory processes and potential conflicts of interest given Donald Trump’s shareholding position in TMTG.
The Securities and Exchange Commission has postponed its decision on the Truth Social Bitcoin and Ethereum ETF until October 8, 2025. This move extends the regulatory review period, affecting investor anticipation of U.S. approval for crypto ETFs.
NYSE Arca submitted the listing application for the ETF, which uses branding from Truth Social, a company founded by Donald Trump. Trump holds a significant stake in Trump Media & Technology Group, impacting the ETF’s market positioning.
The delay impacts market expectations, with crypto communities becoming increasingly focused on regulatory actions. Spot Bitcoin and Ethereum ETFs are directly affected, along with anticipated demand and liquidity shifts.
Financial analysts predict potential market volatility due to the delay in ETF approvals. Concerns over ethical issues arise, particularly due to Trump’s involvement in the ETF’s parent company, adding complexity to the regulatory landscape.
Broader implications remain as Solana, XRP, and other altcoin ETFs face similar scrutiny. Market impacts for these tokens are under close observation, pending further developments and potential SEC decisions for their respective ETF applications.
Historical trends show spot ETF delays often lead to short-term market flux, followed by potential rallies post-approval. Price volatility could influence liquidity and trading volumes, with investors weighing risks tied to regulatory timelines.
Quote from Accountable.US, Advocacy Organization: “The proposed rule change is rife with political, personal, and business conflicts of interest with the president’s company.”
